Hep3B Orthotopic Model


Hep3B is a well-established human hepatocellular carcinoma (HCC) cell line widely used in liver cancer research. It exhibits characteristics of HCC, including growth in anchorage-independent conditions and the expression of liver-specific markers. Hep3B is a valuable tool for investigating HCC biology, evaluating therapeutic interventions, and screening anti-cancer agents. Researchers utilize this cell line to study liver cancer pathogenesis, identify potential targets, and develop novel treatment strategies.

Model Details

Cancer Type: Liver Canacer
Model Name: Hep3B
Mouse Strain: Nu/Nu
Treatment Data Available: N/A

Hep3B Survival

Survival of Hep3B after orthotopic intrahepatic injection of Nu/Nu mice (n=5)

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content